A phase I, first in human, open-label, dose finding study evaluating the safety and pharmacokinetics of AMG 706 [motesanib] in subjects with advanced solid tumors

Trial Profile

A phase I, first in human, open-label, dose finding study evaluating the safety and pharmacokinetics of AMG 706 [motesanib] in subjects with advanced solid tumors

Completed
Phase of Trial: Phase I

Latest Information Update: 14 May 2013

At a glance

  • Drugs Motesanib (Primary)
  • Indications Breast cancer; Carcinoid tumour; Colorectal cancer; Gastrointestinal stromal tumours; Sarcoma; Solid tumours; Thyroid cancer
  • Focus Adverse reactions; Pharmacokinetics; Therapeutic Use
  • Most Recent Events

    • 10 Jun 2007 Results have been published.
    • 27 Sep 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top